Is Align Technology Inc (ALGN) undervalued? · P/E 35, rev $4.00B
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
This page asks whether Align Technology Inc (ALGN) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported ALGN revenue for 2024-12-31 was $4.00B. Net income was $421.4M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new ALGN 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare ALGN to the stock page model before you treat a low multiple as a gift.
Not investment advice.